Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15

The board of Embecta Corp. (NASDAQ:EMBC) has announced that it will pay a dividend of $0.15 per share on the 13th of June. This means the annual payment is 4.9% of the current stock price, which is above the average for the industry.

We've discovered 3 warning signs about Embecta. View them for free.
Advertisement

Embecta's Projected Earnings Seem Likely To Cover Future Distributions

Impressive dividend yields are good, but this doesn't matter much if the payments can't be sustained. Embecta was earning enough to cover the previous dividend, but it was paying out quite a large proportion of its free cash flows. By paying out so much of its cash flows, this could indicate that the company has limited opportunities for investment and growth.

Looking forward, earnings per share is forecast to rise exponentially over the next year. Assuming the dividend continues along recent trends, we think the payout ratio will be 19%, which makes us pretty comfortable with the sustainability of the dividend.

historic-dividend
NasdaqGS:EMBC Historic Dividend May 22nd 2025

Check out our latest analysis for Embecta

Embecta Doesn't Have A Long Payment History

Looking back, the dividend has been stable, but the company hasn't been paying a dividend for very long so we can't be confident that the dividend will remain stable through all economic environments. The last annual payment of $0.60 was flat on the annual payment from3 years ago. Embecta hasn't been paying a dividend for very long, so we wouldn't get to excited about its record of growth just yet.

Dividend Growth Potential Is Shaky

Some investors will be chomping at the bit to buy some of the company's stock based on its dividend history. Let's not jump to conclusions as things might not be as good as they appear on the surface. Over the past five years, it looks as though Embecta's EPS has declined at around 35% a year. Such rapid declines definitely have the potential to constrain dividend payments if the trend continues into the future. However, the next year is actually looking up, with earnings set to rise. We would just wait until it becomes a pattern before getting too excited.

In Summary

Overall, we don't think this company makes a great dividend stock, even though the dividend wasn't cut this year. The company hasn't been paying a very consistent dividend over time, despite only paying out a small portion of earnings. Overall, we don't think this company has the makings of a good income stock.

It's important to note that companies having a consistent dividend policy will generate greater investor confidence than those having an erratic one. Meanwhile, despite the importance of dividend payments, they are not the only factors our readers should know when assessing a company. To that end, Embecta has 3 warning signs (and 2 which are potentially serious) we think you should know about. Is Embecta not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks.

Valuation is complex, but we're here to simplify it.

Discover if Embecta might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:EMBC

Embecta

A medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally.

Undervalued with proven track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
GANX logo
Lou_Basenese on Gain Therapeutics ·

The Market Is Sleeping on This Parkinson's Biotech - And I Think That's a Mistake

Fair Value:US$7.673.0% undervalued
25 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.0% undervalued
52 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
TE
BUSER logo
TechMegaTrends on Bambuser ·

Bambuser is today the only listed company in Europe that simultaneously possesses an 85% gross margin, proprietary AI infrastructure for the

Fair Value:SEK 238.2687.2% undervalued
33 users have followed this narrative
0 users have commented on this narrative
14 users have liked this narrative
HE
HedgeY
CSTM logo
HedgeY on Constellium ·

Constellium jet another cyclical aluminum processor, or a mispriced aluminum platform?

Fair Value:US$3412.8% undervalued
5 users have followed this narrative
0 users have commented on this narrative
4 users have liked this narrative

Updated Narratives

DA
davidlsander
UBI logo
davidlsander on Ubisoft Entertainment ·

Is Ubisoft the Market’s Biggest Pricing Error? Why Forensic Value Points to €33 Per Share

Fair Value:€33.886.0% undervalued
76 users have followed this narrative
7 users have commented on this narrative
1 users have liked this narrative
FA
PMCK logo
FA_Trader on PMCK Berhad ·

Sunway Healthcare’s valuation spike may shine light on smaller healthcare names like PMCK

Fair Value:RM 0.2623.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
CG
BLCO logo
CG86 on Bausch + Lomb ·

$BLCO & $COO The Silence BEFORE the AGM: A Retail Investor’s Timeline, Findings, and Opinion on SUSPICIOUS SILENCE!

Fair Value:US$39.2357.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TR
tripledub
MSFT logo
tripledub on Microsoft ·

Everyone's Terrified Microsoft Will Keep Spending. I'm Terrified They'll Stop.

Fair Value:US$3956.4% overvalued
51 users have followed this narrative
3 users have commented on this narrative
42 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.235.0% undervalued
52 users have followed this narrative
1 users have commented on this narrative
17 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$587.3128.4% undervalued
1365 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

SP
EOSE logo
spearfishingcap on Eos Energy Enterprises ·

AI Slop

1
|
0
MA
BBW logo
manunogueira on Build-A-Bear Workshop ·

Why so high p/e?

0
|
0